Dassault Systèmes franchit un nouveau cap dans les Sciences de la vie avec une plateforme d'IA unifiée connectant science, médecine et patients

Dassault Systèmes has completed its $1.8 billion acquisition of ArisGlobal and created a unified native AI platform called 3D UNIV+RSES that connects the entire therapeutic lifecycle—from drug discovery through clinical development, manufacturing, and real-world patient outcomes. The company appointed Dr. Ashwini Zenooz as Executive Vice President and General Manager of Life Sciences and Healthcare to lead the integration of MEDIDATA, BIOVIA, and ArisGlobal brands.